65,437 trials
CML
Primary: Percentage of Participants Without Molecular Relapse Within 6 Months After Starting the TFR Phase — 12 Participants
Heart Failure · Obesity
Primary: Number of Participants With Arrhythmia as Detected by ICD — 0 participants
Opioid-use Disorder
Primary: Intervention PCP Confidence in Assessing and Treating OUD — 6; 11; 8; 1 Participants
Plaque Psoriasis
Primary: Number and Percentage of Participants With Response of Psoriasis Skin Lesions to Treatment at Week 12 — 43; 1 Participants
Esophageal Cancer
Primary: Rate of Participants Who Were Alive at 2 Years — 71; 53 percentage of participants
Frailty
Primary: Recruitment Rate — 17 Participants
Tobacco Use Cessation · Cancer Prevention
Primary: Intervention Feasibility & Acceptability — 4.87; 4.71; 4.83 score on a scale
Beta-Thalassemia Major · Sickle Cell Disease
Primary: Number of Treated Participants With Successful Neutrophil and Platelet Engraftment — 3; 4; 3; 4 Participants
HIV Infection · HIV-1 Infection · Mycobacterium Avium Complex (MAC)
Primary: Pharmacokinetics of Maraviroc and Rifabutin AUC 0-12/24 — 1026.2; 847.0; 4221.9; 331.9 h*μg/L
Recurrent Fallopian Tube Carcinoma · Recurrent Ovarian Carcinoma · Recurrent Primary Peritoneal Carcinoma
Primary: Event Free Survival — 3.48; 4.96 months
Pelvic Organ Prolapse · Surgery · Postoperative Pain
Primary: Primary Postoperative Pain Measured by the Numerical Rating Scale (NRS) — 3.0; 4.0; 3.75 score on a scale — p=0.39
Cataract
Primary: Percentage of All-implanted Subjects Achieving Monocular Best Corrected Distance Visual Acuity (BCDVA) of 0.3 logMAR or Better at Month 12 Postoperative — 99.7…
Insulin Resistance
Primary: Percent Change in Hepatic Insulin Sensitivity — -19.2; 5.8; -33.66; 113.7 percent change
Meningitis · Meningococcal Meningitis · Meningococcal Infections
Primary: Geometric Mean Titers (GMTs) of Meningococcal Serogroups A, C, Y, And W Antibodies Following Vaccination With 3 Lots of MenACYW Conjugate Vaccine — 84.9; 96.5; 97.9; 326…
Diabetic Neuropathy Peripheral
Primary: Change in Pain Intensity — -1.47; -1.25 units on a scale